Hyperthermia increases the therapeutic efficacy of survivinT34A in mouse tumor models

Cancer Biology and Therapy

Volumn 12, Issue 6, 2011, Pages 523-530

  Li, Zhi Mian ^a   Zhao, Yu Wei ^a   Zhao, Cheng Jian ^a   Zhang, Xiao Ping ^a   Chen, Li Juan ^a   Wei, Yu Quan ^a   Yang, Han Shuo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; Colon carcinoma; Combination treatment; Gene therapy; Hyperthermia; Survivin

Indexed keywords

LIPOSOME; PROTEIN SURVIVINT34; SURVIVIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER MODEL; CONTROLLED STUDY; FEMALE; HYPERTHERMIA; IN VITRO STUDY; MICROVASCULATURE; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR NECROSIS;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COMBINED MODALITY THERAPY; FEMALE; GENE THERAPY; HYPERTHERMIA, INDUCED; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED BALB C; MUTANT PROTEINS; MUTATION, MISSENSE; NEOPLASM TRANSPLANTATION; NEOPLASMS; REPRESSOR PROTEINS;

EID: 80052844656     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.6.15983     Document Type: Article

References (47)

1. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3:401-10; PMID: 12042762; DOI: 10.1038/nrm830.
2. Zhen HN, Zhang X, Hu PZ, Yang TT, Fei Z, Zhang JN, et al. Survivin expression and its relation with proliferation, apoptosis and angiogenesis in brain gliomas. Cancer 2005; 104:2775-83; PMID: 16284993; DOI: 10.1002/cncr.21490.
3. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152:43- 9; PMID: 9422522.
4. Shen W, Wang CY, Wang XH, Fu ZX. Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res 2009; 28:81; PMID: 19527508; DOI: 10.1186/1756- 9966-28-81.
5. Ma H, Nguyen C, Lee KS, Kahn M. Differential roles for the coactivators CBP and p300 on TCF/betacatenin- mediated survivin gene expression. Oncogene 2005; 24:3619-31; PMID: 15782138; DOI: 10.1038/ sj.onc.1208433.
6. Zhou H, Luo Y, Lo JF, Kaplan CD, Mizutani M, Mizutani N, et al. DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor. Proc Natl Acad Sci USA 2005; 102:10846-51; PMID: 16040807; DOI: 10.1073/ pnas.0502208102.
7. Decker WK, Qiu J, Farhangfar F, Hester JH, Altieri DC, Lin AY. A retrogen plasmid-based vaccine generates high titer antibody responses against the autologous cancer antigen survivin and demonstrates antitumor efficacy. Cancer Lett 2006; 237:45-55; PMID: 16019131; DOI: 10.1016/j.canlet.2005.05.035.
8. Altieri DC. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 2006; 18:609-15; PMID: 16934447; DOI: 10.1016/j.ceb.2006.08.015.
9. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3:46-54; PMID: 12509766; DOI: 10.1038/nrc968.
10. Verdecia MA, Huang H, Dutil E, Kaiser DA, Hunter T, Noel JP. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat Struct Biol 2000; 7:602-8; PMID: 10876248; DOI: 10.1038/77929.
11. Muchmore SW, Chen J, Jakob C, Zakula D, Matayoshi ED, Wu W, et al. Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein Survivin. Mol Cell 2000; 6:173-82; PMID: 10949038.
12. Tu SP, Jiang XH, Lin MC, Cui JT, Yang Y, Lum CT, et al. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. Cancer Res 2003; 63:7724-32; PMID: 14633697.
13. cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 2000; 97:13103-7; PMID: 11069302; DOI: 10.1073/pnas.240390697.
14. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002; 277:3247-57; PMID: 11714700; DOI: 10.1074/jbc. M106643200.
15. Grossman D, Kim PJ, Schechner JS, Altieri DC. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 2001; 98:635-40; PMID: 11149963; DOI: 10.1073/ pnas.230450097.
16. Mesri M, Wall NR, Li J, Kim RW, Altieri DC. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 2001; 108:981-90; PMID: 11581299.
17. Olie RA, Simões-Wüst AP, Baumann B, Leech SH, Fabbro D, Stahel RA, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 2000; 60:2805-9; PMID: 10850418.
18. Uchida H, Tanaka T, Sasaki K, Kato K, Dehari H, Ito Y, et al. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo. Mol Ther 2004; 10:162-71; PMID: 15233951; DOI: 10.1016/j. ymthe.2004.05.006.
19. Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, et al. Altered expression of c-IAP1, survivin and Smac contributes to chemotherapy resistance in thyroid cancer cells. Cancer Res 2006; 66:4263-72; PMID: 16618750; DOI: 10.1158/0008- 5472.CAN-05-3248.
20. Konduri S, Colon J, Baker CH, Safe S, Abbruzzese JL, Abudayyeh A, et al. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression. Mol Cancer Ther 2009; 8:533-42; PMID: 19258429; DOI: 10.1158/1535-7163.MCT-08-0405.
21. Kowal CD, Bertino JR. Possible benefits of hyperthermia to chemotherapy. Cancer Res 1979; 39:2285-9; PMID: 376118.
22. Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol) 2007; 19:418-26; PMID: 17493790.
23. Rau B, Wust P, Hohenberger P, Löffel J, Hünerbein M, Below C, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg 1998; 227:380- 9; PMID: 9527061; DOI: 10.1097/00000658- 199803000-00010.
24. Rossi A, Ciafrè S, Balsamo M, Pierimarchi P, Santoro MG. Targeting the heat shock factor 1 by RNA interference: A potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 2006; 66:7678-85; PMID: 16885369; DOI: 10.1158/0008- 5472.CAN-05-4282.
25. Ohnishi K, Ohnishi T. Hyperthermic sensitizers targeting heat-induced signal transductions. Ann Cancer Res Ther 2007; 15:35-40; DOI: 10.4993/acrt.15.35.
26. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997; 17:5317-27; PMID: 9271409.
27. 34 by flavopiridol enhances tumor cell apoptosis. Cancer Res 2003; 63:230-5; PMID: 12517802.
28. Fortugno P, Beltrami E, Plescia J, Fontana J, Pradhan D, Marchisio PC, et al. Regulation of survivin function by Hsp90. Proc Natl Acad Sci USA 2003; 100:13791-6; PMID: 14614132; DOI: 10.1073/ pnas.2434345100.
29. Dohi T, Salz W, Costa M, Ariyan C, Basadonna GP, Altieri DC. Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in mice. EMBO Rep 2006; 7:438-43; PMID: 16470228.
30. Dohi T, Okada K, Xia F, Wilford CE, Samuel T, Welsh K, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004; 279:34087-90; PMID: 15218035; DOI: 10.1074/jbc.C400236200.
31. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 2001; 40:1117-23; PMID: 11170436; DOI: 10.1021/ bi001603q.
32. Wang Z, Fukuda S, Pelus LM. Survivin regulates the p53 tumor suppressor gene family. Oncogene 2004; 23:8146-53; PMID: 15361831; DOI: 10.1038/ sj.onc.1207992.
33. Blanc-Brude OP, Mesri M, Wall NR, Plescia J, Dohi T, Altieri DC. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 2003; 9:2683-92; PMID: 12855648.
34. Virrey JJ, Guan S, Li W, Schönthal AH, Chen TC, Hofman FM. Increased survivin expression confers chemoresistance to tumor-associated endothelial cells. Am J Pathol 2008; 173:575-85; PMID: 18599610; DOI: 10.2353/ajpath.2008. 071079.
35. Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC, et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 2001; 158:1757-65; PMID: 11337373; DOI: 10.1016/ S0002-9440(10)64131-4.
36. Tran J, Master ZB, Yu JL, Rak J, Dumont DJ, Kerbel RS. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 2002; 99:4349-54; PMID: 11917134; DOI: 10.1073/ pnas.072586399.
37. Peng XC, Yang L, Yang LP, Mao YQ, Yang HS, Liu JY, et al. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34→Ala mutant. J Exp Clin Cancer Res 2008; 27:46; PMID: 18816410; DOI: 10.1186/1756-9966-27-46.
38. Pajonk F, Arndt van O, William HM. Hyperthermiainduced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Res 2005; 65:4836-43; PMID: 15930304; DOI: 10.1158/0008-5472.CAN- 03-2749.
39. Roca C, Luca P, Donatella V, Anna C, Paul D, Peter C, et al. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res 2003; 63:1500-7; PMID: 12670896.
40. Schumacher T, Ruehland C, Schultheiss C, Brinkman M, Roedel F, Reiser COA, et al. Advanced antigen delivery of murine survivin: Chimeric virus-like particles in cancer vaccine research. Int J Biomed Sci 2007; 3:199-205.
41. + T cell immunity to mouse survivin. J Immunol 2006; 177:8410-21; PMID: 17142738.
42. Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD. Differential requirements for survivin in hematopoietic cell development. Proc Natl Acad Sci USA 2005; 102:11480-5; PMID: 16055565; DOI: 10.1073/pnas.0500303102.
43. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16:948-58; PMID: 11959843; DOI: 10.1101/gad.981002.
44. Yang L, Cao Z, Yan H, Wood WC. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003; 63:6815-24; PMID: 14583479.
45. Song CW. Effect of local hyperthermia on blood flow and microenvironment: a review. Cancer Res 1984; 44:4721-30; PMID: 6467226.
46. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004; 6:447-58; PMID: 15542429; DOI: 10.1016/j.ccr.2004.09.028.
47. Liu JY, Wei YQ, Yang L, Zhao X, Tian L, Hou JM, et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 2003; 102:1815-23; PMID: 12750177; DOI: 10.1182/blood-2002- 12-3772.